Alzheimer's progression dynamics — modelling the neurodegenerative decay §38 named out of reach, directly on the plasticity layer as the structural inverse of addiction's gain (the B‑ii half of the convergence, closed)

The neurodegenerative-progression axis chapter 38 named out of reach is modelled here directly on the plasticity layer, as the structural inverse of addiction's gain. Progression accumulates irreversible structural loss, the degenerated circuit responds less, symptomatic levers relieve without rebuilding, and the only handle lives on the decay rate -- disease modification. A person with dementia remains a person.

The Alzheimer's threshold-levers chapter applied the inherited lever frame to Alzheimer's and produced the third and deepest partial fit in the series. It reached the instantaneous symptomatic operating point richly — across all three levers, with a split corrective sign — but it found the dominant Alzheimer's fault, the PROG neurodegenerative-progression axis (the cumulative, irreversible loss of synapses and neurons that is the disease), out of reach of any instantaneous lever, for the deepest reason in the series: it is a loss, not a fold (the ADHD lesson), a progression over time — a plasticity (E0-layer) variable, not an instantaneous operating point (the addiction lesson), and, beyond both, a degeneration — an E0 decay that is the structural inverse of addiction's E0 gain. §38 named that axis with six real genes (APP, PSEN1, PSEN2, MAPT, APOE, TREM2) and graded it [F] NOT REACHED, honestly. That naming was one half of a convergence — the point where the threshold-leverisation route meets the plasticity-dynamics route — and it is the exact inverse of the addiction convergence the previous chapter closed. This chapter is the other half. It models the decay axis directly by reusing the E0 plasticity connectome (the PlasticConnectome of §26 — the kernel, the coupling map, the order-parameter machinery, imported, not re-derived) and applying to that frozen kernel the structural inverse of E0's Hebbian consolidation: a slow, progressive connectivity attrition — the defining structural feature of neurodegeneration, synapse and neuron loss — where the addiction chapter drove the connectome's mass up, this drives it down. The grounding is honestly disanalogous to §37: the addiction reward sign was read out of an engine signal (M5 dopamine reward-prediction error), but the engine has no degeneration signal — it is a healthy emergent atlas. So this module does not claim to ground the loss sign in an engine pathology signal; it grounds the baseline being lost (the frozen M9 coordination anchor, the engine's own emergent structure) and the guard read-only, and the loss direction is grounded as the structural inverse of the E0 gain (neurodegeneration is, by definition, progressive loss of connectivity). Five pre-registered sign-only predictions all hold, and all survive a decay-rate sweep (the anti-tuning guard), each the inverse of a §37 result. D1 — progressive degeneration: progression accumulates structural loss monotonically (the connectivity lost from the kernel rises 0 → 2.23 → 4.04 → 5.52 → 7.23 → 8.50 over 0–24 epochs) and coordination falls with it. D2 — loss of responsiveness: a degenerated connectome responds less to the same coordinating cue than a healthy one — progressive functional decline, the exact mirror of cue-reactivity. D3 — the levers do not rebuild: the symptomatic cue (the B‑i reachable instant axis) leaves the cumulative structural loss exactly unchanged, and at deep degeneration even the maximum cue cannot return the circuit to the healthy resting anchor (a ceiling set by the surviving structure) — relief without disease modification: the convergence seam, exhibited dynamically, and exactly why cholinesterase inhibitors and memantine are symptomatic only. D4 — the structural-variable guard: with the decay rate set to zero the connectome stays identical to the kernel and the coordination returns to the frozen M9 anchor (R ≈ 0.38961) bit-for-bit — degeneration is a structural-loss variable, which is precisely why the instantaneous levers cannot reach it. D5 — the dynamics handle: a lower decay rate preserves strictly more structure at equal progression time, while the symptomatic cue has no handle on the structural trajectory at all — the handle lives only on the progression axis, the disease-modification direction (where the anti-amyloid antibodies act). So the two halves of the convergence meet in one disorder, the exact inverse of addiction: the threshold frame (B‑i) names the decay unreachable for instant levers; the plasticity-dynamics frame (B‑ii) exhibits the decay (D1–D2), shows the levers do not rebuild it (D3), proves it is a structural variable they cannot reach (D4), and shows the only handle is on the progression axis (D5). Addiction consolidates a trace the levers cannot erase; Alzheimer's loses a substrate the levers cannot rebuild — the same E0 layer met from opposite directions. No new mechanism, no new tuned constant; the engine is read-only; the E0 layer is imported, not re-derived. The connectivity loss is the progression as a structural quantity, never the felt quality of memory, loss, or selfhood in dementia (Axis-A firewall — consciousness_claim = 0); a person living with dementia remains a person; only the signs are asserted, and every magnitude (the rate, the identity of the real degeneration mechanism) is [O]. efficacy = 0; not medical advice; no cure, reversal, prevention, or halt of progression; the hard problem stays open.

What §38 named out of reach — and the inverse convergence this chapter closes

The threshold-levers chapter did two things. It reached a genuine surface — the instantaneous symptomatic operating point, across all three levers with a split sign, where the established symptomatic pharmacology (cholinesterase inhibitors, memantine) acts as directions on a lever. And it named, by gene, an axis it could not reach. That out-of-reach axis is the dominant one: the neurodegenerative progression — the cumulative, irreversible loss of synapses and neurons, the process that drives the disease from mild forgetting to global failure, the discriminant that makes Alzheimer's a degeneration rather than an imbalance. §38 named it with six real genes — the amyloid precursor APP, the γ-secretase subunits PSEN1 and PSEN2, tau MAPT, the risk allele APOE, and the microglial receptor TREM2 — carried each with its own promoter read alongside, but graded [F] NOT REACHED for the lever frame. The reason was tripled, and it made Alzheimer's the deepest partial fit in the series. First, the PROG axis is a loss, not a fold: an instantaneous lever moves an operating point, and no operating-point shift sets the amplitude of a cumulative process — the lesson ADHD taught. Second, it is a progression over time: it accrues through the plasticity (E0) layer rather than an instantaneous operating point — the lesson addiction taught. And third — new to Alzheimer's — it is a degeneration: a cumulative, irreversible loss, an E0 decay that is the structural inverse of addiction's E0 gain.

That third sense is the hinge of this chapter, and it is worth stating precisely. Addiction's out-of-reach axis was the E0 plasticity layer met as accumulation: the circuit consolidates a trace, writing into the connectome something the instantaneous levers cannot erase. Alzheimer's out-of-reach axis is the same E0 layer met as loss: the degeneration removes substrate from the connectome, deleting something the instantaneous levers cannot rebuild. The two disorders touch the same plasticity dynamics from opposite directions — one as a trace written, one as a substrate erased. So Alzheimer's is the disorder where the threshold-leverisation route and the plasticity-dynamics route meet as the mirror image of where they met in addiction. §38 named the decay out of reach for the levers; it did not model the decay. This chapter models it. It takes the dynamics route to the same axis the lever route could only name, and in doing so it closes the inverse convergence: the decay the threshold frame declared unreachable is here exhibited directly, and the variable that actually moves the trajectory — the rate of the decay itself — is supplied, while the symptomatic levers are shown to have no handle on it at all.

Reusing the E0 plasticity layer, applying its structural inverse

The first discipline of this chapter is reuse, exactly as it was for addiction. The decay lives in the plasticity dynamics, and the framework already has a plasticity dynamics: the E0 layer, whose PlasticConnectome holds the engine's micro-eddy connectome — the frozen ephaptic kernel W₀ — together with the coupling-versus-bias map and the order-parameter machinery that reads its coordination. This module does not re-derive any of that. It imports the E0 connectome wholesale — the same class, the same kernel W₀, the same coupling map, the same read-out — so there is exactly one plasticity layer in the framework and every result that rests on it inherits its guarantees. What differs from §37 is which direction of that layer is exercised. The addiction chapter drove a reward bias through E0's potentiating Hebbian update, growing a retained trace — the connectome's structure went up. This chapter applies the structural inverse: a slow, progressive connectivity attrition, the defining structural feature of neurodegeneration — synapses and neurons are lost, and the connectome's mass goes down. The handover anticipated exactly this — an E0 decay would need its own sign-grounding, a “coupling-weakening / loss direction,” the literal inverse of the gain — and that is what attrition is.

The consequence is that this chapter introduces no new plasticity machinery and no new tuned constant. The kernel is E0's; the coupling map k = κ / (1 − |b|) (raising coupling with a cue, capped at twice κ) is E0's; the order parameter is E0's. The structural read is the connectivity lost from the kernel, ‖W₀‖ − ‖W‖ — the exact inverse of the addiction chapter's retained trace ‖W−W₀‖ (there the connectome gained mass, here it loses it). The decay rate is a representative [O] value, exactly as the addiction learning rate, the absolute Hz, and the ring geometry are [O]; and crucially the signs asserted below are required to hold over a sweep of that rate (anti-tuning), so no number is fit to a target. Everything downstream — the accumulating loss, the falling coordination, the persistence of the loss under symptomatic levering, the handle on the rate — is then a property of the E0 connectome under attrition, read out, never re-fit. The engine tree is re-emerged read-only and confirmed byte-unchanged (0fbf4988…), and the module registers as the seventeenth atlas citizen (AD-T3b-D).

Grounding the loss read-only — and the honest disanalogy with addiction

Here the grounding diverges from §37 in a way that must be stated plainly, because it is the chapter's central honesty. The addiction chapter grounded its one modelling choice — that reward is a positive drive bias — in an engine signal: the learned-field stage (M5) implements a dopamine reward-prediction error, and the engine itself says, read-only, that reward potentiates (the rewarded eddy's laid-down probability rises well above an unrewarded control), forcing the sign. This chapter has no such engine signal to call on. The frozen engine is a healthy emergent atlas: it has no amyloid, no tau, no synapse-loss variable, no degeneration of any kind — which is the very reason the E0 layer had to add plasticity in the first place, and the reason §38 named this axis out of reach. So this module does not, and honestly cannot, claim to read the loss sign out of an engine pathology signal. It would be an overclaim to pretend otherwise, and the chapter refuses it.

What the module does ground read-only is two things. First, the baseline being lost: the structure degeneration removes is the engine's own emergent coordination — the frozen M9 coordination anchor, W₀ at R ≈ 0.38961 — read directly from the imported connectome. The thing that is degenerating is not invented; it is the engine's coordinated structure. Second, the guard: with the decay process off, the engine is recovered bit-for-bit, as the D4 section shows. The loss direction is then grounded not in a signal but definitionally, and as the structural inverse of the E0 gain: neurodegeneration is, by the meaning of the word, a progressive loss of connectivity — the inverse of consolidation's mass growth. That is a defensible sign, and it is the only thing asserted: the module claims the sign of cumulative structural loss and its consequences, never a magnitude, and never that this attrition is the biology. The rate of loss and the identity of the real degeneration mechanism — amyloid aggregation, tau pathology, synaptic and neuronal loss, neuroinflammation — are [O], heterogeneous, and locked. The disanalogy with §37 is not a weakness; it is the chapter being exact about what it can and cannot ground.

D1 — progressive degeneration: the loss accumulates

The first prediction is the defining one, and it is the inverse of incentive sensitisation. Driving the connectome with the attrition process over a rising number of progression epochs and reading the connectivity lost after each, the loss grows monotonically: at 0, 4, 8, 12, 18, 24 epochs the connectivity lost from the kernel is 0, 2.23, 4.04, 5.52, 7.23, 8.50. Each additional block of progression strips the circuit a little further from its healthy structure, and the lost mass never returns. And the coordination falls with it: as the connectome loses mass, the order parameter R declines from the healthy anchor toward the incoherent floor — deeper progression leaves both less surviving structure and lower coordination capacity. This is progressive degeneration in its structural form: the cumulative, accruing loss that is the disease, the exact mirror of addiction's accumulating gain — where the gain trained the circuit into a progressively stronger learned state, the decay strips it into a progressively weaker degenerated one. It is precisely the behaviour §38 named out of reach for any instantaneous lever, because an instantaneous lever has no notion of accumulation over time at all.

The sign is what is asserted, not the curve. The direction — connectivity loss monotonically increasing in progression, coordination falling — is grounded as the structural inverse of the gain (degeneration is loss), and it is the claim; the exact increments are [O], reproducible artifacts of the decay rate, not fitted quantities. And the claim is checked against the anti-tuning guard: the monotone loss holds over the whole decay-rate sweep, and at every rate the deeper epoch leaves strictly less surviving mass and lower R, so it is a property of the dynamics under attrition, not an artefact of one rate. The neurodegenerative progression that §38 could only name is here a growing structural loss with a grounded direction.

D2 — loss of responsiveness: the degenerated circuit reacts less to the same cue

The second prediction is the functional-decline substrate, and it is the inverse of cue-reactivity. After the circuit has been degenerated by progression, present it with the same coordinating cue that a healthy circuit would see, and measure the coordinated response. The degenerated connectome responds less: its cue-evoked coordination falls below the healthy circuit's, and — the structural reason — its resting coordination already sits at or below the healthy anchor. The lost structure has moved the circuit into a lower-coordination basin, so the same cue evokes a smaller coordinated response than it would in a circuit that had not degenerated. This is the mechanistic substrate of progressive functional decline: the same input, the same world, evokes less and less coordinated response as the substrate is lost — the exact mirror of cue-reactivity, where a sensitised circuit reacted more to an unchanged input. Addiction over-responded to a cue it had learned; Alzheimer's under-responds to a cue it has lost the structure to meet.

The discipline is the same as §37's: assert only the sign that is robust. The claim is the response-falls-below-healthy comparison — the degenerated circuit's cue response is less than the healthy circuit's, with its resting coordination at or below the healthy anchor — holding across the decay-rate × depth sweep, shallow and deep. The exact magnitudes around it stay [O]. So loss of responsiveness is recorded as what it reliably is — a degenerated circuit responds less to the same cue — and not as more than the dynamics support. The functional-decline substrate is exhibited; the numbers are not fit.

D3 — the levers do not rebuild: relief without disease modification

The third prediction is the convergence seam itself, made dynamic, and it is the inverse of extinction-persistence. Take a degenerated circuit and apply the symptomatic cue — a coordinating drive, the very instant axis the §38 levers operate on, the structural stand-in for raising cholinergic tone or rebalancing the network. The cue lifts the instant operating point: while it is applied, the coordination rises. But it leaves the structural loss exactly unchanged. The cue is a read-time coupling — it changes how strongly the surviving connections are driven, but it adds no mass — so the connectivity lost from the kernel is identical before and after, at every depth and every rate. And there is a ceiling: at deep degeneration, even the maximum cue (the coupling cap) cannot return the circuit to the healthy resting anchor — the maximum-cue coordination, R ≈ 0.342 after deep loss, sits below the healthy anchor 0.38961. The surviving structure sets a hard ceiling on what any amount of symptomatic drive can recover.

The contrast with addiction is the whole point, and it is exact. There, extinction removed the drive but not the learned trace: stopping the reward took away what the instant levers could move and left the consolidated memory they could not. Here, the symptomatic lever removes the symptom but not the structural loss: raising the instant operating point relieves the functional deficit transiently and leaves the cumulative degeneration untouched. Relief is real; disease modification is not. This is the structural correlate of the clinical fact the §38 firewall insisted on: cholinesterase inhibitors and memantine act on the instantaneous operating point and do not slow neurodegeneration. The seam where the two routes meet is no longer a statement about reachability in the abstract; it is a measured invariance — the part the symptomatic lever lifts and the part it cannot touch, separated by whether the change adds structure or merely drives it. The invariance holds across the whole sweep, so it is a property of the loss, not of one rate. The direction is forced (the symptomatic cue leaves the loss unchanged); the magnitudes are [O].

D4 — the structural-variable guard: why the instant levers cannot reach it

The fourth prediction is the guard that proves the §38 verdict from the inside, and it is the module's invariance check, the mirror of addiction's plasticity-variable guard. Set the decay rate to zero — progression off — and run the same protocol. The connectome stays identical to the kernel, the connectivity lost is exactly zero, and the coordination returns to the frozen M9 anchor (R ≈ 0.38961) bit-for-bit. The degeneration, in other words, does not exist without the progression process. The loss is not a property of the operating point or of any instantaneous drive; it is a property of the decay. And because the loss exists only when the connectivity is allowed to attrite — only as a cumulative structural variable — it is, by construction, something no instantaneous lever can reach: a drive lever or an ionic lever moves an operating point now, and an operating point shifted now reverts now, exactly as the symptomatic cue showed in D3. This is why §38's levers named the PROG axis out of reach: the axis is not on the instantaneous surface at all. It is a structural loss that runs underneath it.

The guard doubles as the module's byte-level invariance proof. With the decay rate at zero the connectome is the kernel, the engine tree re-emerges unchanged, and the M0–16 subtree is identical — so the whole degeneration construction is a pure add-on: switch off the one new ingredient (progressive attrition) and the result collapses back onto the frozen engine with nothing left over. A new chapter that vanishes cleanly when its one new variable is zeroed is a chapter that has added a reading, not altered the engine. It is the same guarantee the addiction chapter gave with its learning rate; here it is given with the decay rate, and it lands on the same frozen anchor.

D5 — the dynamics handle: the handle lives only on the progression axis

The fifth prediction is what the dynamics route can offer that the lever route could not — a handle on the trajectory — and it is the inverse of the spacing handle. The addiction chapter found a handle on the gain in the schedule of exposure (spaced beat massed). The handle here is different in a way that is itself the finding: it lives only on the progression axis. Vary the decay rate and the structural outcome moves — a lower decay rate preserves strictly more structure at equal progression time (less cumulative loss, more surviving mass, at every epoch across the sweep). That is a real handle, and it points at exactly one thing: the rate of the degeneration, the disease-modification direction. By contrast, the symptomatic cue has no handle on the structural trajectory at all — as D3 established, it leaves the cumulative loss invariant at every depth. So the dynamics frame supplies the one handle the symptomatic frame could not, and it is on the progression axis alone: you can change where the structure ends up only by changing the decay, never by driving the operating point.

This is the constructive close, and it grounds the real-world distinction the §38 firewall drew. D4 shows why the instantaneous levers cannot reach the PROG axis (it is a structural-loss variable that does not exist without the decay); D5 shows what can — a handle on the decay rate, the disease-modification direction. It is exactly the structural separation between the symptomatic agents (cholinesterase inhibitors, memantine), which drive the operating point and have no handle on the loss, and the progression-modifiers (the anti-amyloid antibodies, lecanemab and donanemab), which act on the progression axis itself — and which, the §38 chapter was careful to note, only modestly slow the rate of decline, with serious caveats. The handle is asserted as a sign (lower decay rate preserves more structure; the cue preserves none), holding across the epochs sweep; the magnitudes are [O]. It is named as a structural handle on a structural loss, never as a clinical instruction, a dose, or a claim that any agent halts the disease.

The two halves meet — and the firewall

With the five results in hand the inverse convergence is closed, and it can be stated cleanly. §38 (the B‑i half) applied the threshold-lever frame and found it reaches Alzheimer's instantaneous symptomatic surface but names the neurodegenerative decay out of reach — triply, as a loss, as a progression, and as a degeneration that is the structural inverse of addiction's gain. This chapter (the B‑ii half) takes the plasticity-dynamics route to that same axis and exhibits the decay directly: it accumulates with progression (D1), it makes the circuit under-respond to an unchanged cue (D2), it survives symptomatic levering of the operating point (D3), it vanishes without the decay process (D4, which is exactly why the instant levers miss it), and its only handle is on the progression rate itself (D5). The two routes through the framework — threshold-leverisation and plasticity-dynamics — meet in one disorder, as the exact mirror image of where they met in addiction: the lever route names the decay unreachable for instant levers honestly, and the dynamics route supplies the variable that moves it and shows the symptomatic levers cannot. Addiction consolidates a trace the levers cannot erase; Alzheimer's loses a substrate the levers cannot rebuild. Neither half overclaims; together they describe Alzheimer's defining axis from both sides. No new mechanism, no new tuned constant, the E0 layer imported rather than re-derived, the engine byte-unchanged.

The firewall is absolute and must be stated in full, and for Alzheimer's it carries a human boundary that is not decoration. The connectivity lost is the neurodegenerative progression as a structural quantity — a change in the mass of a connectome model — and it is never a claim about the felt quality of memory, loss, recognition, or selfhood in dementia (Axis-A firewall — consciousness_claim = 0, the hard problem stays open). A person living with dementia remains a person. The cumulative loss modelled here is a substrate-degeneration boundary, not a subtraction of the person; nothing in this mechanism licenses treating anyone as an empty shell or a lost cause, and the chapter's own forbidden-claim discipline rejects that framing outright. Real neurodegeneration is heterogeneous — amyloid-β aggregation, tau and neurofibrillary pathology, synaptic and neuronal loss, microglial and neuroinflammatory dysfunction, network failure, cerebrovascular contribution — and this module asserts only the sign of a single cumulative structural loss, never that this attrition is the biology; the identity of the real degeneration mechanism is owed and graded [O]. The loss direction is grounded as the structural inverse of the E0 gain (the engine has no degeneration signal, the honest disanalogy with §37); every magnitude — the rate, the increments — is [O], and the signs survive a decay-rate sweep. Nothing here is a cure, a reversal, a prevention, a way to halt or slow the progression, a treatment, a recommendation, or a dose. medium_efficacy_tested = 0; signs only, never magnitudes fit to a target; this is not medical advice, not a diagnosis, not a treatment protocol, and not a cure, reversal, or prevention.